Thyroid Cancer

Menopausal women who have 41 or more reproductive years have more than double the risk for developing thyroid cancer compared with women who have 30 or fewer reproductive years, according to study data.

The FDA granted fast track designation to AIC100, a chimeric antigen receptor T-cell therapy, for the treatment of anaplastic thyroid cancer and refractory poorly differentiated thyroid cancer, according to the agent’s manufacturer.

Endocrinologists must do more to reduce overdiagnosis of common, low-risk thyroid cancers and tailor any treatments to reduce potential harm, according to a speaker at the American Association of Clinical Endocrinology virtual meeting.

April is Head and Neck Cancer Awareness Month.

An updated guideline for best practices in managing anaplastic thyroid cancer stresses the need for patient-centered care, considering disease stage and quality of life before attempting aggressive disease management.

Surveillance after treatment for low-risk thyroid cancer is a balancing act that must consider treatment modality and patient concerns about recurrence, but several considerations can help stratify who should receive follow-up screenings.

Adults with differentiated thyroid cancer had greater likelihood for severe COVID-19 outcomes with older age and at least one comorbidity, but cancer-related factors did not increase risks, according to a study findings.

A study found that any amount of physical activity protects against fractures in middle age people. It was the top story in endocrinology last week.

Living in an area with higher levels of outdoor artificial nighttime light appeared associated with higher risk for developing thyroid cancer, according to an observational study published in Cancer.

Although many cancer survivors go on to live healthy, cancer-free lives, the prospect of facing cancer again is an ongoing concern.